Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval
Go back to Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval| Agilent Technologies Inc (NYSE: A) | Delayed: 137.71 -0.86 (0.62%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $138.57 | 52 Week High | $48.63 | |||
| Open | $137.59 | 52 Week Low | $34.15 | |||
| Day High | $139.06 | P/E | 63.75 | |||
| Day Low | $136.14 | EPS | $2.16 | |||
| Volume | 1,131,440 | |||||
| (NASDAQ: AUTL) | Delayed: 1.47 +0.02 (1.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.45 | 52 Week High | $ | |||
| Open | $1.46 | 52 Week Low | $ | |||
| Day High | $1.54 | P/E | N/A | |||
| Day Low | $1.46 | EPS | $ | |||
| Volume | 452,708 | |||||
